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Assignment of a single disulfide bridge in rat liver methionine
adenosyltransferase
MarõÂa L. MartõÂnez-Chantar and MarõÂa A. Pajares
Instituto de Investigaciones BiomeÂdicas `Alberto Sols' (CSIC-UAM), Madrid, Spain
Rat liver methionine adenosyltransferase incorporated 8 mol of N-ethylmaleimide per mol of subunit upon
denaturation in the presence of 8 m urea, whereas 10 such groups were labelled when dithiothreitol was also
included. This observation prompted a re-examination of the state of the thiol groups, which was carried out
using peptide mapping, amino acid analysis and N-terminal sequencing. The results obtained revealed a disulfide
bridge between Cys35 and Cys61. This disulfide did not appear to be conserved because cysteines homologous to
residue 61 do not exist in methionine adenosyltransferases of other origins, therefore suggesting its importance
for the differential aspects of the liver-specific enzyme.
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Methionine adenosyltransferases (MATs) are a family of
cytosolic proteins that have been exceptionally well conserved
during evolution [1]. The information encoding MAT is present
in the genome of all organisms studied to date, except for some
metanogenic archaebacteria [2,3]. The importance of this
family of enzymes is due to the key role of their product,
S-adenosylmethionine (AdoMet), as the main methyl donor
for transmethylation reactions and the propylamine supplier
for polyamine synthesis following decarboxylation [4]. It is
synthesized from ATP and methionine, and pyrophosphate and
inorganic phosphate are also formed as side products [5]. MAT
enzymes show several common features: they appear as
oligomeric proteins in all tissues and organisms studied, Mg2+
ions are needed for activity, monovalent cations (K+) are
activators of these enzymes, most of the enzyme forms show
sigmoidal kinetics for their substrates, and they exhibit
tripolyphosphatase activity [4]. In mammals, two isoenzymes
have been detected, one ubiquitous (MAT II) and another liver
specific [6]. This latter protein appears in two oligomeric
forms, a tetramer (MAT I) and a dimer (MAT III), composed of
the same type of subunit [7,8]. The dimer form of MAT differs
from MAT I in its lower affinity for methionine. Decreases in
MAT activity have been observed in several liver diseases, and
in these cases changes in the MAT I/III ratio have been
detected, the dimer being the prevalent form [9]. These data
have led to speculation about the role of MAT I and MAT III in
the liver, and the mechanisms that control the ratio of the
forms [4].
The rat liver MAT gene has been cloned and its product
found to be composed of 396 amino acid residues, including
10 cysteines [10,11]. Several experiments demonstrating the
importance of such residues in the activity and oligomeric state
of rat liver MAT have been reported previously. Thiopropyl±
Sepharose chromatography of rat liver MAT I and elution in the
presence of reduced glutathione (GSH) led to changes in its
methionine kinetics, as well as in its electrophoretical mobility
[12]. Rat liver MAT is inhibited by oxidized glutathione
(GSSG) inactivation, which produces dissociation [12]. Inhibi-
tion by GSSG is modulated by GSH [12]. Substitution of Cys
residues by Ser using site-directed mutagenesis produces
changes in the MAT I/III ratio compared with the wild-type
enzyme. This shift is specially important in the Cys69Ser
mutant, which appears only as dimers [13]. Chemical
modification of two sulfhydryl groups with N-ethylmalei-
mide produces inactivation of either MAT I or MAT III,
and dissociation of the former to a dimer [14].
Modification by nitric oxide donors also leads to enzyme
inactivation, which is not observed in the Cys121Ser
mutant [15,16]. Finally, neither N-ethylmaleimide nor nitric
oxide modifications, even using denatured MAT, lead to
the labelling of more than eight Cys groups [17,18].
These results indicate the presence of two nonaccessible
sulfhydryl groups, which may be involved in a protein
disulfide.
Homology among the several MAT proteins cloned to date is
high [1], and hence the conservation of residues important for
its function and structure, such as Cys, is expected. However,
neither the number of Cys residues (5±10 per monomer) nor
their localization in the sequence is constant [13]. In fact, only
Cys35, Cys57 and Cys105 (numbered according to the rat liver
sequence) are present in most of the sequences from
Escherichia coli to mammals, while Cys9, Cys61, Cys69,
Cys121 and Cys377 seem to be liver specific [13]. These
differences between liver and nonliver MATs, the importance
that Cys69 seems to have in the oligomerization, and the
possible presence of a disulfide bond may be related to the
fact that only liver forms appear as stable tetramers and
dimers. Therefore, this study focused on the identification
of the nonaccessible Cys residues of rat liver MAT I/III
and clearly establishing its possible involvement in a
disulfide bond.
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M A T E R I A L S A N D M E T H O D S
Materials
Methionine, ATP, benzamidine, phenylmethanesufonyl fluoride
(PMSF), soybean trypsin inhibitor (STI), trypsin and dithio-
threitol were from Sigma Chemical Co. N-Ethylmaleimide was
purchased from Serva (Germany). [2-3H]ATP (20 Ci´mmol21)
and [1,414C] N-ethylmaleimide (2±10 mCi´mmol21) were
supplied by Amersham International (Little Chalfont, UK)
and ARC Inc. (St Louis, MO, USA), respectively. DEAE±
Sephacel, phenyl Sepharose CL-4B and blue Sepharose CL-6B
were purchased from Pharmacia LKB. Optiphase HiSafe 3
scintillation fluid was obtained from E & G Wallac (Milton
Keynes, UK). Endoproteinase±Glu-C was from Boehringer
Mannheim. Cation exchanger AG-50W-X4, Bio-Gel A 1.5-m,
Biogel HTP, Bio-Rad protein assay and the electrophoresis
reagents were from Bio-Rad. The Ultrasphere ODS C18 column
was obtained from Beckman (San RamoÂn, CA, USA). Glass
fibre filters and YM-30 ultrafiltration membranes were
products of Whatman Ltd (Maidstone, UK) and AMICON
Corp. (Beverly, MA, USA), respectively. Urea, 2-mercaptoetha-
nol and dimethylsulfoxide were purchased from Merck
(Darmstadt, Germany). All other buffers and reagents were of
the best quality available commercially.
Purification of rat liver MAT
Rat liver MAT I and MAT III were purified as described by
Pajares et al. [12], excluding the thiopropyl Sepharose
chromatography.
Determination of MAT activity
MAT activity was measured essentially as described by Cabrero
et al. [7]. The final reaction volume was 250 mL and contained
saturating concentrations of the substrates [5 mm methionine
and 5 mm [2-3H] ATP (1 Ci´mol21)]. Incubation was carried
out for 30 min at 37 8C, and was stopped by the addition of
3 mL of distilled water. After separation of the product,
radioactivity was determined in the presence of 1 mL acetic
acid and 10 mL scintillation fluid.
Sulfhydryl group labelling
Purified proteins, MAT I and MAT III (1 mg), were lyophilized
and resuspended in 100 mL of 85 mm Hepes/Na pH 8
containing 85 mm KCl, 58 mm MgCl2 and 8 m urea, in the
presence or absence of a 10-fold molar excess of dithiothreitol
over the expected sulfhydryl groups, and the solution was
incubated for 1 h at 37 8C. [14C] N-Ethylmaleimide (5 mCi)
was then added with cold N-ethylmaleimide in a fivefold molar
excess over the total content of -SH groups (-SH groups of
dithiothreitol plus -SH groups of protein) and the alkylating
reaction was carried out at room temperature for 1 h. To stop
the reaction a 10-fold molar excess of 2-mercaptoethanol was
added and the protein was precipitated by the addition of 1 mL
10% (v/v) trichloroacetic acid. A portion of the sample
(100 mg) was then loaded onto glass fibre filters, washed five
times with 10 mL trichloroacetic acid 10%, dried and counted
in the presence of 10 mL scintillation fluid in order to calculate
the number of free -SH groups in each case. The remaining
protein (0.9 mg) was washed three times with trichloroacetic
acid 10%, and the final pellet was resuspended in 100 mL of
buffer and subjected to proteolysis.
Proteolysis of the samples
Trypsinization was carried out as described by Deigner et al.
[19]. Endoproteinase±Glu-C treatment was performed at 37 8C
for 5 h, and initiated by the addition of 1 : 50 (w/w) of the
protease to the labelled protein sample in 100 mL of 20 mm
ammonium bicarbonate pH 7. The reaction was stopped by
freezing and the samples were lyophilized.
Peptide mapping
Proteolysed samples were resuspended in 100 mL of 0.1%
trifluoroacetic acid (TFA) in water (solvent A) and injected on a
C18 HPLC column (250  4 mm; 10 mm particle diameter)
equilibrated in this same buffer. Chromatography was carried
out at 1 mL´min21, and after a 5-min washing period a three-
step gradient was developed. The first step included a 13 min
gradient from 100% solvent A to 21% 0.1% TFA/50%
propanol-2 in water (solvent B). The second step was developed
for 60 min to 79% solvent B and the third step for 10 min until
100% solvent B. Fractions were collected each 0.5 min and
divided, 50 mL were counted and the rest lyophilized.
Repurification of the isolated peptides was carried out using
the same HPLC column and a gradient described previously
using 0.1% TFA in water (solvent A) and 0.1% TFA in 50%
acetonitrile (solvent B) [17].
Amino acid analysis and N-terminal sequencing of the
N-ethylmaleimide-labelled peptides
Purified peptides were hydrolysed in the presence of 6 m HCl
for 2 h at 110 8C, and amino acid analysis of the samples was
carried out on a Beckman System 6300 Autoanalyzer as
described previously by Deigner et al. [19]. As for peptide
sequencing, samples were analysed on an Applied Biosystems
Procise Sequencer.
SDS/PAGE
Denaturing gel electrophoresis was performed in order to
establish the purity of the protein samples. For this purpose,
samples containing 10±20 mg of protein were loaded onto 10%
polyacrylamide/SDS gels under reducing conditions using the
buffer system described by Laemmli [20]. Detection was
performed using either Coomasie Brilliant Blue or silver
staining.
Protein concentration determination
The protein concentration of the samples was measured using
the method described by Bradford [21], with the Bio-Rad
protein assay kit and BSA as the standard.
R E S U L T S A N D D I S C U S S I O N
Purified rat liver MAT can be labelled in its sulfhydryl groups
using either N-ethylmaleimide or nitric oxide donors [14,15].
Maximum labelling was achieved using urea-denatured
MAT I/III, and in that case only 8 of the 10 Cys sulfhydryls
present in the sequence were modified [17,18]. However, the 10
residues were chemically modified when purified MAT I/III
were incubated with urea and a 10-fold molar excess of
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dithiothreitol. These results indicated the presence of two
nonreacting thiols in each subunit, and suggested the possible
presence of a disulfide bridge. Intersubunit disulfides have not
been detected by SDS/PAGE under nonreducing conditions, but
changes in electrophoretic mobility were obtained upon
thiopropyl±Sepharose chromatography [12], thus suggesting
an intrasubunit disulfide. Moreover, inhibition and oxidation
constants for rat liver MAT in glutathione redox buffers have
been calculated either in the presence or absence of
thioltransferases, and the mechanism of the reaction appeared
to involve the formation of intramolecular disulfides [12,22]. In
order to study this possibility rat liver MAT I and MAT III were
isolated to homogeneity (Fig. 1), and urea denatured either in
the presence or absence of dithiothreitol. The samples were
then labelled with 14C-N-ethylmaleimide and proteolysed using
trypsin. Table 1 shows the peptides expected to be labelled by
this procedure. Peptides were separated on reverse-phase HPLC
and the peptide maps obtained were compared (Fig. 2). Urea-
denatured samples (U) of either MAT I or MAT III showed less
labelling than those treated with urea and dithiothreitol (UDTT;
Fig. 2A,C). In the latter case, most of the radioactivity appeared
early in the chromatogram as a broad peak (fraction 29-UDTT),
that coincided with the elution position for excess dithiothreitol.
Moreover, both samples presented very similar profiles except
for the disappearance of a shoulder on fraction 31-UDTT of the
dithiothreitol/urea-denatured protein (Fig. 2A, arrow) and the
apparition of a broader peak on fraction 42/43-U of the urea-
treated MAT (Fig. 2C, arrow), either I and III. Changes in this
area of the chromatograms were also detected when the
absorbance profiles at 214 nm were compared (Fig. 2B,D). The
absorbance for fraction 29-UDTT/31-UDTT was reduced on
the urea-treated protein and a new peak corresponding to
fraction 43-U was detectable (Fig. 2D, arrow). These changes
were studied in more detail, and for this purpose the labelled
peaks were collected and HPLC analysed again using a second
set of conditions.
Peaks derived from dithiothreitol/urea-treated samples
after the second HPLC analysis showed the presence of
only one N-ethylmaleimide peptide, except for that corres-
ponding to fraction 41-UDTT (Fig. 3A). In this later case two
labelled peptides were separated. Repurified-labelled peaks
were divided into three aliquots that were used for endo-
proteinase Glu-C treatment, amino acid analysis and N-terminal
sequencing. Proteolysis with endoproteinase Glu-C was carried
out in order to distinguish between those peptides containing
several labelled residues, because the presence of glutamic acid
residues in their sequences between Cys residues allowed this
protease to cut tryptic peptides to obtain others containing a
single Cys (Table 1). Fractions 46-UDTT, 51-UDTT and 91-
UDTT contained protease susceptible peptides (Fig. 3D±F).
Two labelled peaks were obtained upon endoproteinase Glu-C
proteolysis of peaks 46-UDTT and 91-UDTT (Fig. 3D,F), and
three from 51-UDTT (Fig. 3E). Amino acid analysis and
N-terminal sequencing allowed the identification of these
peptides as those corresponding to residues 55±62, 104±160
and 104±126, respectively (Table 2).
Urea-denatured MAT I and MAT III peptides were also
analysed using a second HPLC gradient and the isolated
peptides were divided into four aliquots and used for
endoproteinase Glu-C treatment, dithiothreitol incubation,
amino acid analysis and N-terminal sequencing. The results
obtained were similar to those observed in the dithiothreitol/
urea-treated samples, except for fraction 43-U. Upon incubation
with dithiothreitol this new peak was reanalysed on HPLC
using the first gradient. One peak of radioactivity was obtained
(fraction 46, Fig. 4A), in addition to two peaks of absorbance
Fig. 1. SDS/PAGE of rat-liver-purified MAT I and MAT III. Rat liver
MAT I and MAT III were purified as described in Materials and methods.
Five micrograms of MAT I (A) and 8 mg of MAT III (B) were loaded onto
a 10% SDS/PAGE gel and detected using Coomasie Brilliant Blue. The
molecular mass of the markers is given on the left-hand side of the figure,
and the Mr of the MAT band appears in the centre.
Table 1. Cysteine-containing tryptic peptides derived from rat liver methionine adenosyltransferase. The sequences of the tryptic peptides containing
the 10 cysteine residues of MAT are shown below. Cysteine residues are underlined.
Peptide sequence Cysteine-contained residues Peptide
MNGPVDGLCDHSLSEEGAFMFTSESVGEGHPDK Cys9 1±33
ICDQISDAVLDAHLK Cys35 34±48
VACETVCK Cys57 and Cys61 55±62
TGMVLLCGEITSMAMIDYQR Cys69 63±85
TGMVLLCGEITSMAMIDYQRVVR Cys69 63±88
TGMVLLCGEITSMAMIDYQRVVRDTIK Cys69 63±92
TCNVLVALEQQSPDIAQCVHLDR Cys105 and Cys121 104±126
TCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIVLAHK Cys105, Cys121 and Cys150 104±160
NEEDVGAGDQGLMFGYATDETEECMPLTIVLAHK Cys150 127±160
AGLCR Cys312 309±313
AGLCRR Cys312 309±314
AGLCRRVLVQVSYAIGVAEPLSISIFTYGTSK Cys312 309±340
TACYGHFGR Cys377 375±383
TACYGHFGRSEFPWEVPK Cys377 375±392
q FEBS 2000 Methionine adenosyltransferase shows a disulfide bond (Eur. J. Biochem. 267) 135
corresponding to fractions 31 and 46 (Fig. 4B). This behaviour
is compatible with the presence of a disulfide bridge linking
one peptide containing one cysteine to another containing two.
Amino acid analysis and N-terminal sequencing of these
fractions revealed that they correspond to peptides 34±48 and
55±62, respectively (Table 2). Therefore, a disulfide bond
between Cys35 and Cys57 or Cys61 was present in the protein
samples. To finally clarify this point a portion of fraction 43-U
was treated with endoproteinase Glu-C, the labelled peak
purified and used for N-terminal sequencing. The residues
identified corresponded to VA-, results that were compatible
with labelling on Cys57, and hence, clearly established the
presence of a disulfide between Cys35 and Cys61 of the MAT
sequence. The same results were obtained using either MAT I
or MAT III.
Cysteines have been demonstrated to be important for the
activity and oligomerization of rat liver MAT [13,14]. The
importance of some of these residues suggested that their
conservation should be fundamental for this family of proteins.
Surprisingly, neither Cys69 nor Cys121 appeared in all the
known sequences, but only in the liver-specific enzymes [13].
The same was true for Cys61, while Cys35 appeared in almost
all the cloned MATs. This fact revealed some peculiarities of
the hepatic forms probably related to its appearance as a
tetramer and dimers, which may represent an advantage when
responding to changes in substrate concentration. The avail-
ability of X-ray diffraction data for E. coli MAT [23] made
possible the construction of a model for the rat liver enzyme
structure [16]. In this model Cys35, Cys57, Cys61 and Cys69
Fig. 2. Tryptic peptide maps of 14C-N-ethylmaleimide-labelled MAT III. Purified rat liver MAT III was urea-denatured in either the presence (sample
UDTT, A and B) or absence (sample U, C and D) of dithiothreitol. Protein samples were then chemically modified in their free -SH groups using 14C-N-
ethylmaleimide and proteolysed with trypsin. Peptides were separated on HPLC as described in Materials and methods at a flow rate of 1 mL´min21, and
500 mL fractions were collected. In order to detect the labelled peptides containing free -SH groups, a small sample (50 mL) of the fractions was counted in
the presence of scintillation fluid (A and C). In addition, the absorbance at 214 nm was also recorded (B and D). The peaks containing the labelled peptides
were collected separately and kept for further purification. The figure shows the part of the HPLC chromatogram where radioactivity was detected. Arrows
indicate those areas of the chromatogram where changes were detected. Identical results were obtained using rat liver purified MAT I.
Table 2. N-terminal sequencing and amino acid analysis of the labelled
peptides. Peptides isolated after proteolysis of the urea/dithiothreitol-
treated rat liver MAT III were repurified and used for the determination of
their amino acid content and N-terminal sequencing. The results obtained
are shown below and the cysteine residues are indicated on the side column.
Identical results were obtained using urea/dithiothreitol-treated rat liver
MAT I.
N-ethylmaleimide-
labelled
tryptic
fraction
Amino
acid
analysis Sequence
Cysteine-
containing
residues
31 34±48 Cys35
35 127±160 NEE- Cys150
41 309±313 AGL- Cys312
309±314
46 55±62 VA-E Cys57 and Cys61
51 104±160 T- Cys105, Cys121 and Cys150
55 375±383 TA-Y Cys377
57 375±392 Cys377
82 1±33 MNGP- Cys9
91 104±126 Cys105 and Cys121
93 309±340 Cys312
101 63±85 Cys69
104 63±88 Cys69
106 63±92 Cys69
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appeared very close in the structure, with the last three residues
located in a b sheet that seemed to be the area of contact for
two dimers. In fact, the Cys69Ser mutant of the protein led only
to the production of dimer forms, a result that suggested its
direct relationship with MAT oligomerization [13]. Moreover,
only two of these cysteines seemed to be oriented properly and
within the bonding distance as judged from the rat liver
MAT crystal structure (J. Sanz-Aparicio and M. A. Pajares,
unpublished results), Cys35 and Cys61. Our experimental data
therefore coincide with the structural data in that the residues
involved in the disulfide bond are those expected.
Disulfide bond formation between cysteine residues is one of
the post-translational modifications most dependent on the
protein conformation. Even when the cytosol is a strongly
reducing environment and disulfide linked proteins are scarce
[24±26], some of these bonds have been detected in proteins
such as the cytosolic branched-chain amino transferase and the
human glucocorticoid receptor [27,28]. The possibility exists
that during protein folding the local concentration of sulf-
hydryls becomes high enough to allow disulfide bridge pro-
duction in such a reducing environment. In fact, optimal rates
of oxidative folding are obtained at significant reductant
concentrations [29]. Comparison of MAT sequences showed
that the liver enzymes have evolved with increasing numbers of
cysteines in a particular location of the protein. The presence of
a disulfide bridge at Cys35±Cys61, close to the area of contact
between the dimers, could give more stability to the b sheet,
and hence to the whole oligomer. Disappearance of this bond
may destabilize this part of the structure allowing easier
aggregation or dissociation as observed with E. coli over-
expression of rat liver MAT [30]. The implication of
intramolecular disulfides in protein oligomerization is not
Fig. 3. Analysis of the 14C-N-ethylmaleimide labelled MAT III tryptic peptides. Tryptic peptides derived from MAT III were collected and repurified
using a second HPLC gradient as described in Materials and methods. A flow rate of 1 mL´min21 was used and 500 mL fractions were collected. All the
peaks analysed showed the presence of a unique labelled peptide, except for fraction 41 dithiothreitol (A). For further characterization of these peptides an
aliquot was treated with endoproteinase Glu-C in order to distinguish between those containing two cysteines. The results obtained for the tryptic peptides are
shown as follows: (B) 31-UDTT, (C) 41-UDTT, (D) 46-UDTT, (E) 51-UDTT, (F) 91-UDTT, (G) 93-UDTT and (H) 104-UDTT. The figure shows that part of
the HPLC chromatograms where radioactivity was detected. Identical results were obtained when MAT I tryptic peptides were treated using the same
procedures.
Fig. 4. Dithiothreitol treatment of fraction
43-U. Fraction 43-U obtained from the
urea-denatured MAT III sample, after
purification using the two HPLC methods
described in Materials and methods, was
incubated with dithiothreitol. The effect of this
treatment was then analysed using the first
HPLC purification gradient. Again 500 mL
fractions were collected and 50 mL samples of
those counted in the presence of scintillation
fluid. (A) The radioactivity profile detected
upon fraction collection, (B) the absorbance
recorded at 214 nm. Peaks of interest are
indicated by an arrow. Identical results were
obtained for fraction 43-U of urea-denatured
MAT I.
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new and has been observed in some cell-surface or secreted
proteins [31], however, to the best of our knowledge no
description of such a role for cytosolic enzymes has been made
to date. Finally, in addition to the importance of this finding for
the stability of the protein oligomers, our results provide
evidence of a new example of a disulfide-containing cytosolic
protein.
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